Minerva Batugo
Pfizer (United States)(US)
Publications by Year
Research Areas
Nitric Oxide and Endothelin Effects, Glaucoma and retinal disorders, Retinal Diseases and Treatments, Neonatal Respiratory Health Research, PI3K/AKT/mTOR signaling in cancer
Most-Cited Works
- → Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 6. Structure−Activity Studies of Orally Bioavailable, 2-Pyridone-Containing Peptidomimetics(2002)142 cited
- → Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 8. Pharmacological Optimization of Orally Bioavailable 2-Pyridone-Containing Peptidomimetics(2003)115 cited
- → Characterization of Human Corneal Epithelial Cell Model As a Surrogate for Corneal Permeability Assessment: Metabolism and Transport(2009)71 cited
- → A Novel Nitric Oxide Releasing Prostaglandin Analog, NCX 125, Reduces Intraocular Pressure in Rabbit, Dog, and Primate Models of Glaucoma(2010)69 cited
- → Discovery Pharmacokinetic Studies in Mice Using Serial Microsampling, Dried Blood Spots And Microbore Lc–MS/MS(2012)48 cited
- → Intraocular Pressure–Lowering Activity of NCX 470, a Novel Nitric Oxide–Donating Bimatoprost in Preclinical Models(2015)37 cited
- → A dual acting compound with latanoprost amide and nitric oxide releasing properties, shows ocular hypotensive effects in rabbits and dogs(2011)32 cited
- → Synthesis of novel nitric oxide (NO)-releasing esters of timolol(2009)8 cited
- → Cardiovascular differentiation of imatinib and bosutinib in the rat(2013)3 cited
- Ocular Pharmacokinetics in Single Compound and Cassette Dose Studies Following Sub–Tenon Administration in Dutch–Belted Rabbits(2005)